Search research articles
Contact Us
Filters
Showing results (201-210 of 663) with videos related to
Page
of 67
Sort By:
The Journal of Infectious Diseases
|
January 6, 2007
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen
Steven G Deeks, Jing Lu, Rebecca Hoh, et al.
Journal of Virology
|
November 21, 2008
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine
Roger Paredes, Manish Sagar, Vincent C Marconi, et al.
AIDS Research and Human Retroviruses
|
October 13, 2022
Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States
Karine Dubé, Chadwick K Campbell, Shadi Eskaf, et al.
AIDS Research and Therapy
|
July 25, 2006
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells
Laurel E Nomura, Brinda Emu, Rebecca Hoh, et al.
AIDS (London, England)
|
December 12, 2013
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1
Alonso Heredia, Charles Davis, Mohammed N Amin, et al.
AIDS (London, England)
|
September 10, 2020
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents
Sushama Telwatte, Peggy Kim, Tsui-Hua Chen, et al.
AIDS (London, England)
|
July 12, 2012
Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients
Van N Selby, Rebecca Scherzer, Christopher F Barnett, et al.
BMC Infectious Diseases
|
November 4, 2005
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment
Serena S Spudich, Annelie C Nilsson, Nicole D Lollo, et al.
JCI Insight
|
August 20, 2024
Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivo
Julie Janssens, Peggy Kim, Sun Jin Kim, et al.
Retrovirology
|
December 20, 2013
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
Jeffrey M Milush, Sandra López-Vergès, Vanessa A York, et al.
Page
of 67
Search research articles
Search
Showing results (201-210 of 663) with videos related to
Sort By:
Page
of 67
The Journal of Infectious Diseases
|
January 6, 2007
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen
Steven G Deeks, Jing Lu, Rebecca Hoh, et al.
Journal of Virology
|
November 21, 2008
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine
Roger Paredes, Manish Sagar, Vincent C Marconi, et al.
AIDS Research and Human Retroviruses
|
October 13, 2022
Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States
Karine Dubé, Chadwick K Campbell, Shadi Eskaf, et al.
AIDS Research and Therapy
|
July 25, 2006
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells
Laurel E Nomura, Brinda Emu, Rebecca Hoh, et al.
AIDS (London, England)
|
December 12, 2013
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1
Alonso Heredia, Charles Davis, Mohammed N Amin, et al.
AIDS (London, England)
|
September 10, 2020
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents
Sushama Telwatte, Peggy Kim, Tsui-Hua Chen, et al.
AIDS (London, England)
|
July 12, 2012
Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients
Van N Selby, Rebecca Scherzer, Christopher F Barnett, et al.
BMC Infectious Diseases
|
November 4, 2005
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment
Serena S Spudich, Annelie C Nilsson, Nicole D Lollo, et al.
JCI Insight
|
August 20, 2024
Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivo
Julie Janssens, Peggy Kim, Sun Jin Kim, et al.
Retrovirology
|
December 20, 2013
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
Jeffrey M Milush, Sandra López-Vergès, Vanessa A York, et al.
Page
of 67